+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antibiotic Market Report by Drug Origin, By Class, By Spectrum of Activity, By Application, Route of Administration, and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 156 Pages
  • July 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5651375
The antibiotic market size is estimated to be USD 47.21 billion in 2021 and is expected to witness a CAGR of 5.22% during the forecast period 2022-2029. The market is expected to grow due to rise in the prevalence of infectious diseases such malaria, HIV/AIDS, tuberculosis, and pneumonia. Other factors driving market expansion include increased regulatory supervision and a significant risk of product failure. However, rise in medication approval costs and the development of antibiotic resistance is expected to limit the market growth

By Drug Origin

Based on drug origin, the market is categorized into synthetic, semisynthetic, natural. In 2021, the synthetic accounted for the highest revenue share due to increased coverage and potency of semisynthetic oral antibiotics against a variety of pathogens.

By Class

Based on class, the market is segmented into quinolone, macrolide, beta lactam & beta lactamase inhibitors. In 2021, the beta lactam & beta lactamase inhibitors segment accounted for the largest revenue share owing to its broad-spectrum action, great efficacy to cure a variety of diseases brought on by a variety of bacterial types and the widespread usage of these antibiotics as treatments for gram-negative infections.

By Spectrum of Activity

On the basis of spectrum of activity, the market is categorized into narrow spectrum antibiotic and broad-spectrum antibiotic. In the global market, the broad-spectrum antibiotic segment accounted for the largest revenue share in 2021 owing to fact that broad-spectrum antibiotics treat a number of disorders.

By Application

Based on application, the market is segmented into animal and human. In 2021, the animal segment accounted for the largest revenue share owing to its less side effects on animal compare to human.

By Route of Administration

Based on route of administration, the market is categorized into oral and intravenous. In 2021, the intravenous accounted for the highest revenue share due to increase in serious diseases.

Regional Markets Asia Pacific held the largest revenue share in the antibiotic market in 2021, and it is predicted to continue to do so throughout the forecast period. This is due to rising over-the-counter medicine sales, rising public awareness of the benefits of antibiotics easier access to antibiotics, and greater antibiotic intake.

Competitor Insights

Some of the key players operating in the antibiotic market are Sanofi, Merck & Co. Inc., Allergan Plc., Abbott Laboratories, GlaxoSmithKline Plc, Mylan N.V., Novartis International AG (Sandoz), F.Hoffmann-La Roche Ltd., Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including drug origin, class, spectrum of activity, application, and route of administration from 2021 to 2029.

Segmentation: Antibiotic Market Report 2021-2029

By Drug Origin (Revenue, USD Billion)

  • Synthetic
  • Semisynthetic
  • Onatural

By Class (Revenue, USD Billion)

  • Quinolone
  • Macrolide
  • Beta Lactam & Beta Lactamase Inhibitors

By Spectrum of Activity (Revenue, USD Million)

  • Onarrow Spectrum Antibiotic
  • Broad Spectrum Antibiotic

By Application (Revenue, USD Billion)

  • Animal
  • Human

By Route of Administration (Revenue, USD Billion)

  • Oral
  • Intravenous

By Region (Revenue, USD Billion)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment
2. Introduction: Antibiotic
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1.Driver 1
4.1.2.Driver 2
4.1.3.Driver 3
4.1.4.Driver 4
4.1.5.Driver 5
4.2.Market Restraint
4.2.1.Restraint 1
4.2.2.Restraint 2
4.2.3.Restraint 3
4.2.4.Restraint 4
4.3.Market Opportunities
4.3.1.Opportunity 1
4.3.2.Opportunity 2
4.3.3.Opportunity 3
4.3.4.Opportunity 4
4.4.Market Trends
4.4.1.Trend 1
4.4.2.Trend 2
4.4.3.Trend 3
4.4.4.Trend 4
4.5.Market Challenges
4.5.1.Challenge 1
4.5.2.Challenge 2
4.5.3.Challenge 3
4.5.4.Challenge 4
5. Market Environment Analysis
5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Antibiotic Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Drug Origin
7.1.Synthetic
7.1.1.Synthetic Market Forecast, 2021-2029 (USD Million)
7.2.Semisynthetic
7.2.1.Semisynthetic Market Forecast, 2021-2029 (USD Million)
7.3.Natural
7.3.1.Natural Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Class
8.1.Quinolone
8.1.1.Quinolone Market Forecast, 2021-2029 (USD Million)
8.2.Macrolide
8.2.1.Macrolide Market Forecast, 2021-2029 (USD Million)
8.3.Beta Lactam & Beta Lactamase Inhibitors
8.3.1.Beta Lactam & Beta Lactamase Inhibitors Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by Application
9.1.Narrow Spectrum Antibiotic
9.1.1.Narrow Spectrum Antibiotic Market Forecast, 2021-2029 (USD Million)
9.2.Broad Spectrum Antibiotic
9.2.1.Broad Spectrum Antibiotic Market Forecast, 2021-2029 (USD Million)
10. Market Analysis by Application
10.1.Animal
10.1.1.Animal Market Forecast, 2021-2029 (USD Million)
10.2.Human
10.2.1.Human Market Forecast, 2021-2029 (USD Million)
11. Market Analysis by Route of Administration
11.1.Oral
11.1.1.Oral Market Forecast, 2021-2029 (USD Million)
11.2.Intravenous
11.2.1.Intravenous Market Forecast, 2021-2029 (USD Million)
12. Regional Market Analysis
12.1.Regional Market Trends
12.2.Regional Market: Comparative Analysis
13. North America Antibiotic Market
13.1.North America Antibiotic Market
13.1.1.North America Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
13.1.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
13.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.2.U.S. Antibiotic Market
13.2.1.U.S. Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
13.2.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
13.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.3.Canada Antibiotic Market
13.3.1.Canada Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
13.3.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
13.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.5. Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14. Europe Antibiotic Market
14.1.Europe Antibiotic Market
14.1.1.Europe Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.1.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.2.Germany Antibiotic Market
14.2.1.Germany Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.2.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.3.UK Antibiotic Market
14.3.1.UK Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.3.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.4.France Antibiotic Market
14.4.1.France Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.4.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.5.Spain Antibiotic Market
14.5.1.Spain Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.5.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.6.Italy Antibiotic Market
14.6.1.Italy Market Size and Forecast, 2021-2029 (USD Million)
14.6.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.6.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.6.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.6.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.6.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.7.Rest of Europe Antibiotic Market
14.7.1.Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
14.7.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
14.7.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
14.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.7.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.7.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15. Asia Pacific Antibiotic Market
15.1.Asia Pacific Antibiotic Market
15.1.1.Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.1.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.2.Japan Antibiotic Market
15.2.1.Japan Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.2.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.3.China Antibiotic Market
15.3.1.China Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.3.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.4.India Antibiotic Market
15.4.1.India Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.4.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.5.South Korea Antibiotic Market
15.5.1.South Korea Market Size and Forecast, 2021-2029 (USD Million)
15.5.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.5.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.5.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.5.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.6.Australia Antibiotic Market
15.6.1.Australia Market Size and Forecast, 2021-2029 (USD Million)
15.6.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.6.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.6.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.6.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.6.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.7.Rest of Asia Pacific Antibiotic Market
15.7.1.Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
15.7.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
15.7.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
15.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.7.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.7.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16. Latin America Antibiotic Market
16.1.Latin America Antibiotic Market
16.1.1.Latin America Market Size and Forecast, 2021-2029 (USD Million)
16.1.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
16.1.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
16.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.1.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.1.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.2.Brazil Antibiotic Market
16.2.1.Brazil Market Size and Forecast, 2021-2029 (USD Million)
16.2.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
16.2.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
16.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.2.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.2.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.3.Mexico Antibiotic Market
16.3.1.Mexico Market Size and Forecast, 2021-2029 (USD Million)
16.3.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
16.3.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
16.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.3.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.3.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.4.Argentina Antibiotic Market
16.4.1.Argentina Market Size and Forecast, 2021-2029 (USD Million)
16.4.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
16.4.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
16.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.4.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.4.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.5.Rest of Latin America Antibiotic Market
16.5.1.Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
16.5.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
16.5.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
16.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.5.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.5.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
17. MEA Antibiotic Market
17.1.MEA Antibiotic Market
17.1.1.MEA Market Size and Forecast, 2021-2029 (USD Million)
17.1.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
17.1.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
17.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.1.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.1.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
17.2.GCC Antibiotic Market
17.2.1.GCC Market Size and Forecast, 2021-2029 (USD Million)
17.2.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
17.2.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
17.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.2.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.2.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
17.3.South Africa Antibiotic Market
17.3.1.South Africa Market Size and Forecast, 2021-2029 (USD Million)
17.3.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
17.3.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
17.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.3.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.3.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
17.4.Rest of MEA Antibiotic Market
17.4.1.Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
17.4.1.1.Market Size and Forecast by Drug Origin, 2021-2029 (USD Million)
17.4.1.2.Market Size and Forecast by Class, 2021-2029 (USD Million)
17.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.4.1.4.Market Size and Forecast by Application, 2021-2029 (USD Million)
17.4.1.5.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
18. Competitor Analysis
18.1.Market Share Analysis, 2021 & 2029
18.2.Competitive Mapping
18.3.Key Players Market Place Analysis
18.4.Major Recent Developments
19. Company Profiles
19.1.Abbott Laboratories
19.1.1.Company Snapshot
19.1.2.Company Overview
19.1.3.Financials
19.1.4.Drug Origin Benchmarking
19.1.5.Recent Developments
19.2.Allergan Plc.
19.2.1.Company Snapshot
19.2.2.Company Overview
19.2.3.Financials
19.2.4.Drug Origin Benchmarking
19.2.5.Recent Developments
19.3.F.Hoffmann-La Roche Ltd.
19.3.1.Company Snapshot
19.3.2.Company Overview
19.3.3.Financials
19.3.4.Drug Origin Benchmarking
19.3.5.Recent Developments
19.4.GlaxoSmithKline Plc
19.4.1.Company Snapshot
19.4.2.Company Overview
19.4.3.Financials
19.4.4.Drug Origin Benchmarking
19.4.5.Recent Developments
19.5.Merck & Co. Inc.
19.5.1.Company Snapshot
19.5.2.Company Overview
19.5.3.Financials
19.5.4.Drug Origin Benchmarking
19.5.5.Recent Developments
19.6.Mylan N.V.
19.6.1.Company Snapshot
19.6.2.Company Overview
19.6.3.Financials
19.6.4.Drug Origin Benchmarking
19.6.5.Recent Developments
19.7.Novartis International AG (Sandoz)
19.7.1.Company Snapshot
19.7.2.Company Overview
19.7.3.Financials
19.7.4.Drug Origin Benchmarking
19.7.5.Recent Developments
19.8.Pfizer Inc.
19.8.1.Company Snapshot
19.8.2.Company Overview
19.8.3.Financials
19.8.4.Drug Origin Benchmarking
19.8.5.Recent Developments
19.9.Sanofi
19.9.1.Company Snapshot
19.9.2.Company Overview
19.9.3.Financials
19.9.4.Drug Origin Benchmarking
19.9.5.Recent Developments
19.10.Teva Pharmaceutical Industries Ltd.
19.10.1.Company Snapshot
19.10.2.Company Overview
19.10.3.Financials
19.10.4.Drug Origin Benchmarking
19.10.5.Recent Developments
19.11. Company 11
19.11.1.Company Snapshot
19.11.2.Company Overview
19.11.3.Financials
19.11.4.Drug Origin Benchmarking
19.11.5.Recent Developments
19.12. Company 12
19.12.1.Company Snapshot
19.12.2.Company Overview
19.12.3.Financials
19.12.4.Drug Origin Benchmarking
19.12.5.Recent Developments
19.13. Company 13
19.13.1.Company Snapshot
19.13.2.Company Overview
19.13.3.Financials
19.13.4.Drug Origin Benchmarking
19.13.5.Recent Developments
19.14. Company 14
19.14.1.Company Snapshot
19.14.2.Company Overview
19.14.3.Financials
19.14.4.Drug Origin Benchmarking
19.14.5.Recent Developments
19.15. Company 15
19.15.1.Company Snapshot
19.15.2.Company Overview
19.15.3.Financials
19.15.4.Drug Origin Benchmarking
19.15.5.Recent Developments
19.16.Others Prominent Players
20. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sanofi
  • Merck & Co. Inc.
  • Allergan Plc.
  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Mylan N.V.
  • Novartis International AG (Sandoz)
  • F.Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.